Challenges in addressing the knowledge gap on endomyocardial fibrosis through community-based studies
- PMID: 32420110
- PMCID: PMC7225430
- DOI: 10.21037/cdt.2019.08.07
Challenges in addressing the knowledge gap on endomyocardial fibrosis through community-based studies
Abstract
Endomyocardial fibrosis (EMF) is a poverty-related disease of unknown origin that afflicts predominantly young people of certain rural areas in low-income countries and can be used to expose global disparities in cardiovascular research. Despite affecting predominantly young people and causing high morbidity and mortality, efforts to understand its mechanisms and natural history have been hampered by the incapacity to detect the early stages of the disease in endemic areas. Dietary, environmental and infectious factors seem to combine in susceptible individuals to give rise to an inflammatory process that leads to endomyocardial damage and scar formation. Lack of awareness by health professionals and low access to health care determine late diagnosis, when complications such as chronic heart failure, thromboembolism and arrhythmia are already present. Open-heart surgery to detach the endocardial fibrous tissue and repair the atrioventricular valve, remains the last resource to prolong patients' survival. Community-based research is therefore needed to understand the epidemiology of EMF, detect early disease, uncover its pathogenesis and explore new therapeutic targets. Our research has shown that echocardiographic screening using standard criteria adds sensitivity and precision to the diagnosis, particularly in asymptomatic disease, providing an opportunity for longitudinal community-based research. However, researchers face major constraints in rural settings where EMF is endemic, including socioeconomic, cultural, geographical and administrative barriers. In presenting our experience we aim to describe the challenges and discuss the lessons learned while implementing community-based research in a highly endemic area in southern Mozambique, one of the poorest countries in the world. Additionally, we discuss how recent advances in medicine-such as use of point-of-care diagnostics, heart failure biomarkers and new imaging techniques-may open new possibilities for high quality research through collaborative partnerships and regional initiatives.
Keywords: Community-based research; endomyocardial fibrosis studies.
2020 Cardiovascular Diagnosis and Therapy. All rights reserved.
Conflict of interest statement
Conflicts of Interest: The series “Cardiovascular Diseases in Low-and Middle-Income Countries” was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare.
Figures


Similar articles
-
Tropical Endomyocardial Fibrosis: Natural History, Challenges, and Perspectives.Circulation. 2016 Jun 14;133(24):2503-15. doi: 10.1161/CIRCULATIONAHA.115.021178. Circulation. 2016. PMID: 27297343 Review.
-
Right ventricular endomyocardial fibrosis (2013 Grover Conference series).Pulm Circ. 2014 Sep;4(3):363-9. doi: 10.1086/676746. Pulm Circ. 2014. PMID: 25621149 Free PMC article. Review.
-
Sepsis Care Pathway 2019.Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019. Qatar Med J. 2019. PMID: 31763206 Free PMC article.
-
A case report of a 40-year-old woman with endomyocardial fibrosis in a non-tropical area: from initial presentation to high urgent heart transplantation.BMC Cardiovasc Disord. 2019 Dec 19;19(1):302. doi: 10.1186/s12872-019-1243-8. BMC Cardiovasc Disord. 2019. PMID: 31881943 Free PMC article.
-
A population study of endomyocardial fibrosis in a rural area of Mozambique.N Engl J Med. 2008 Jul 3;359(1):43-9. doi: 10.1056/NEJMoa0708629. N Engl J Med. 2008. PMID: 18596273
Cited by
-
Use of COX Inhibitors in Plastic Surgery Fibroproliferative Disorders: A Systematic Review.J Pers Med. 2025 Jun 17;15(6):257. doi: 10.3390/jpm15060257. J Pers Med. 2025. PMID: 40559119 Free PMC article. Review.
-
Endomyocardial fibrosis: recent advances and future therapeutic targets.Nat Rev Cardiol. 2025 Aug;22(8):564-576. doi: 10.1038/s41569-025-01138-x. Epub 2025 Feb 26. Nat Rev Cardiol. 2025. PMID: 40011660 Review.
-
Non-coding RNAs: targets for Chinese herbal medicine in treating myocardial fibrosis.Front Pharmacol. 2024 Feb 27;15:1337623. doi: 10.3389/fphar.2024.1337623. eCollection 2024. Front Pharmacol. 2024. PMID: 38476331 Free PMC article. Review.
References
-
- Elmawazini K, Manga P, Nwankwo S, et al. Health gap between developed and developing countries: Does globalization matter? Econ Change Restruct 2019;52:123-38. 10.1007/s10644-017-9219-0 - DOI
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous